Theriva Biologics (TOVX) Interest & Investment Income (2011 - 2026)
Theriva Biologics' Interest & Investment Income came in at $79,000 for Q2 2026, up 46.3% from $54,000 a year earlier but down 3.7% from the prior quarter.
Powered by 
Analysis
Theriva Biologics (TOVX) Interest & Investment Income (2011 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Theriva Biologics reported Interest & Investment Income of $298,000, down 33.2% year-over-year; for FY2025, it was $287,000, down 58.8% from FY2024.
- Interest & Investment Income carries a five-year compound annual growth rate of 45.5% (FY2020 to FY2025).
- Going back by year, Interest & Investment Income was $697,000 in FY2024 (-51.6%), $1.44 million in FY2023 (+181.1%), $512,000 in FY2022 and $6,000 in FY2021 (-86.4%).
- The five-year range for quarterly Interest & Investment Income is $2,000 (Q3 2021) to $382,000 (Q3 2023).
- Year-over-year, Interest & Investment Income increased in 1 of the last eight quarters, with an average decline of 39.5%.
- The fastest year-over-year change in Interest & Investment Income over five years came in Q3 2023 (growth of 124.7%), and the weakest in Q2 2025 (a decline of 68.8%).
- Business Quant data shows TOVX's Interest & Investment Income at $82,000 (Q1 2026), $72,000 (Q4 2025) and $65,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Theriva Biologics | 11.01 Mn | 11.01 Mn | - | 79,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 79,000.00 |
| Mar 31, 2026 | 82,000.00 |
| Dec 31, 2025 | 72,000.00 |
| Sep 30, 2025 | 65,000.00 |
| Jun 30, 2025 | 54,000.00 |
| Mar 31, 2025 | 96,000.00 |
| Dec 31, 2024 | 138,000.00 |
| Sep 30, 2024 | 158,000.00 |
| Jun 30, 2024 | 173,000.00 |
| Mar 31, 2024 | 228,000.00 |
| Dec 31, 2023 | 312,000.00 |
| Sep 30, 2023 | 382,000.00 |
| Jun 30, 2023 | 381,000.00 |
| Mar 31, 2023 | 364,000.00 |
| Dec 31, 2022 | 315,000.00 |
| Sep 30, 2022 | 170,000.00 |
| Jun 30, 2022 | 26,000.00 |
| Mar 31, 2022 | 2,000.00 |
| Dec 31, 2021 | 2,000.00 |
| Sep 30, 2021 | 2,000.00 |
API Access
Theriva Biologics Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=TOVX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "TOVX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=TOVX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();